COVID-19 vaccination programmes are expected to begin next month in many countries including the US the UK and Germany. The Serum Institute of India (SII) is also in the process of submitting the data for the clinical trials of Covishield to the DCGI to seek emergency use authorisation. Adar Poonawalla Founder and CEO SII told media persons on Saturday that the company will seek emergency use authorisation for the Oxford-AstraZeneca COVID-19 vaccine in about two weeks. Union Health Minister Harsh Vardhan had earlier announced that India could have a COVID-19 vaccine by the start of next year and that the